Ravi Yang Sarin - Mar 21, 2022 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Director
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Ravi Yang Sarin
Stock symbol
TOI
Transactions as of
Mar 21, 2022
Transactions value $
$0
Form type
4
Date filed
3/23/2022, 07:37 PM
Previous filing
Nov 16, 2021
Next filing
Nov 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common stock Award $0 +16K $0.00 16K Mar 21, 2022 Direct F1
transaction TOI Common stock Award $0 +7.2K +45% $0.00 23.2K Mar 21, 2022 Direct
holding TOI Common stock 4.11M Mar 21, 2022 LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest in full on November 12, 2022, subject to continued service with the Company through such vesting date.
F2 Reflects securities owned by OncologyCare Partners, LLC. OncologyCare Holdings, LLC is the manager of OncologyCare Partners, LLC, and, Ravi Sarin formerly served as the managing member of OncologyCare Holdings, LLC and continues to have the ability to influence the vote and disposition of the shares in certain circumstances, and thus may be deemed to indirectly beneficially own the shares, which Mr. Ravi disclaims except to the extent of his pecuniary interest therein.